Clinical trial
Prospective Multicenter Observational Cohort Study of Comparative Effectiveness of Disease-modifying Treatments for Myasthenia Gravis
NCT03490539 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Multicenter Observational Cohort Study of Comparative Effectiveness of Disease-modifying Treatments for Myasthenia Gravis
- Lead sponsor
- Duke University
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 7, 2018
- Completion date
- January 31, 2021
- Enrollment
- 82 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
autoimmune diseases, neurological disorder